Dr. Daniel Jacob Becker, MD

Dr. Becker practices at NYU Langone Perlmutter Cancer Center - 34th St in New York, New York.

Dr. Becker's NPI, 1639361546, was assigned on August 14, 2007. Dr. Becker graduated from Albert Einstein College of Medicine in 2002. Dr. Becker holds New York license 233841.

Dr. Becker's primary practice is NYU Langone Perlmutter Cancer Center - 34th St, at 14 Wall St, New York, NY 10005 in New York County. The practice phone is (212) 263-1481.

Dr. Becker's primary practice is NYU Langone Perlmutter Cancer Center - 34th St in New York, New York. Dr. Becker is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Becker to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Becker practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Becker's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Becker is board certified in medical oncology by the American Board of Internal Medicine. Dr. Becker is licensed in New York.

CMS data shows 223 Medicare services from Dr. Becker across 2 procedure codes in 2024, all of them office visits, for 57 Medicare patients. Medicare paid $18,564 for them. Every service was in an office.

CMS counts 57 Medicare patients who saw Dr. Becker in 2024. The largest group is 75 to 84, with 20 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 21% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Becker's median patient age at 69, with 41% women.

In 2016, Dr. Becker wrote 12 Medicare Part D claims. They cover 1 drug, with $77,375 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Becker for performance year 2024, reported as part of a group. Dr. Becker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Becker as offering telehealth.

Dmand AI links 173 papers to Dr. Becker, published from 2009 to 2025. 2020 was the busiest year, with 20. The most frequent topics are Chiroptera, Phylogeny and Animals, Wild. Dr. Becker has published most often in Philos Trans R Soc Lond B Biol Sci. Dr. Becker's most frequent co-authors are Danil Victor Makarov, MD, MHS, Scott Eliot Sherman, MD and Salman Punekar, MD.

Dmand AI links Dr. Becker to 7 clinical trials, 2 of them phase 1/2 studies. 4 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis and Lung Neoplasms. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 33 general payments to Dr. Becker from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Novartis Pharmaceuticals Corporation paid the most, $377.

Dr. Becker graduated from Albert Einstein College of Medicine in 2002.

Dr. Becker is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.